Monopar Therapeutics Inc $107.72 (-3.16, 2.85%)

NASDAQ
97% success, from Analysis 113* of this Model (*Public)
Summary
SHORTBUY: Best moves 9 which gains 915.65, return on capital invested 7.38%
Date Name (*Public) Description Symbol Type Size Action
Date Value Error Logarithmic Error
Details Best Trend by Hindsight Forecast Profit or Loss
Date (*Public) Symbol Strategy Data Origin Slope Sigma Cor % Moves Sigma Moves Gain % Periods Action
Date UTC Location Action Description Object Severity User Action